91 related articles for article (PubMed ID: 8713118)
1. Are cytoskeletal components involved in the control of hepatic carnitine palmitoyltransferase I activity?
Velasco G; Sánchez C; Geelen MJ; Guzmán M
Biochem Biophys Res Commun; 1996 Jul; 224(3):754-9. PubMed ID: 8713118
[TBL] [Abstract][Full Text] [Related]
2. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
3. Activity of carnitine palmitoyltransferase in mitochondrial outer membranes and peroxisomes in digitonin-permeabilized hepatocytes. Selective modulation of mitochondrial enzyme activity by okadaic acid.
Guzmán M; Geelen MJ
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):487-92. PubMed ID: 1332675
[TBL] [Abstract][Full Text] [Related]
4. Evidence against direct involvement of phosphorylation in the activation of carnitine palmitoyltransferase by okadaic acid in rat hepatocytes.
Guzman M; Kolodziej MP; Caldwell A; Corstorphine CG; Zammit VA
Biochem J; 1994 Jun; 300 ( Pt 3)(Pt 3):693-9. PubMed ID: 8010950
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Ca2+/calmodulin-dependent protein kinase II in the activation of carnitine palmitoyltransferase I by okadaic acid in rat hepatocytes.
Velasco G; Guzmán M; Zammit VA; Geelen MJ
Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):211-6. PubMed ID: 9003421
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of carnitine palmitoyltransferase I by hepatocyte swelling.
Guzmán M; Velasco G; Castro J; Zammit VA
FEBS Lett; 1994 May; 344(2-3):239-41. PubMed ID: 7910567
[TBL] [Abstract][Full Text] [Related]
7. Studies on the intracellular localization of acetyl-CoA carboxylase.
Geelen MJ; Bijleveld C; Velasco G; Wanders RJ; Guzmán M
Biochem Biophys Res Commun; 1997 Apr; 233(1):253-7. PubMed ID: 9144433
[TBL] [Abstract][Full Text] [Related]
8. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of protein phosphatases (okadaic acid and tautomycin) block sea urchin development.
Troll W; Sueoka N; Sueoka E; Laskin JD; Heck DE
Biol Bull; 1995; 189(2):201. PubMed ID: 8541399
[No Abstract] [Full Text] [Related]
10. Malonyl-CoA-independent acute control of hepatic carnitine palmitoyltransferase I activity. Role of Ca2+/calmodulin-dependent protein kinase II and cytoskeletal components.
Velasco G; Geelen MJ; Gómez del Pulgar T; Guzmán M
J Biol Chem; 1998 Aug; 273(34):21497-504. PubMed ID: 9705278
[TBL] [Abstract][Full Text] [Related]
11. Loss of response of carnitine palmitoyltransferase I to okadaic acid in transformed hepatic cells.
Velasco G; Passilly P; Guzmán M; Latruffe N
Biochem Pharmacol; 1998 Dec; 56(11):1485-8. PubMed ID: 9827581
[TBL] [Abstract][Full Text] [Related]
12. Tautomycin from the bacterium Streptomyces verticillatus. Another potent and specific inhibitor of protein phosphatases 1 and 2A.
MacKintosh C; Klumpp S
FEBS Lett; 1990 Dec; 277(1-2):137-40. PubMed ID: 2176611
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the cytokeratin cytoskeleton and inhibition of hepatocytic autophagy by okadaic acid.
Blankson H; Holen I; Seglen PO
Exp Cell Res; 1995 Jun; 218(2):522-30. PubMed ID: 7540986
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the AMP-activated protein kinase stimulates rat liver carnitine palmitoyltransferase I by phosphorylating cytoskeletal components.
Velasco G; Gómez del Pulgar T; Carling D; Guzmán M
FEBS Lett; 1998 Nov; 439(3):317-20. PubMed ID: 9845345
[TBL] [Abstract][Full Text] [Related]
15. Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.
Suganuma M; Okabe S; Sueoka E; Nishiwaki R; Komori A; Uda N; Isono K; Fujiki H
J Cancer Res Clin Oncol; 1995; 121(9-10):621-7. PubMed ID: 7559747
[TBL] [Abstract][Full Text] [Related]
16. Impact of protein restriction on the regulation of cardiac carnitine palmitoyltransferase by malonyl-CoA.
Holness MJ; Priestman DA; Sugden MC
J Mol Cell Cardiol; 1998 Jul; 30(7):1381-90. PubMed ID: 9710806
[TBL] [Abstract][Full Text] [Related]
17. The role of actin filaments and microtubules in hepatocyte spheroid self-assembly.
Tzanakakis ES; Hansen LK; Hu WS
Cell Motil Cytoskeleton; 2001 Mar; 48(3):175-89. PubMed ID: 11223949
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
19. Neuronal differentiation of Neuro 2a cells by lactacystin and its partial inhibition by the protein phosphatase inhibitors calyculin A and okadaic acid.
Tanaka H; Katagiri M; Arima S; Matsuzaki K; Inokoshi J; Omura S
Biochem Biophys Res Commun; 1995 Nov; 216(1):291-7. PubMed ID: 7488103
[TBL] [Abstract][Full Text] [Related]
20. Immunodetection of rat Walker 256 tumour mitochondrial carnitine palmitoyltransferase I and II: evidence for the control of CPT II expression by insulin.
Colquhoun A; Curi R
Biochem Mol Biol Int; 1996 Feb; 38(1):171-4. PubMed ID: 8932531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
